Our Solution
Dual-action ultrasound catheter
Our technology aims to reduce post-infarction heart failure, AMI mortality, and readmissions, lowering healthcare burden
Dual-action ultrasound catheter
Our technology aims to reduce post-infarction heart failure, AMI mortality, and readmissions, lowering healthcare burden
Engineering & Innovation
Patent-Pending Catheter Technology
Our catheter developed at ETH Zurich is designed to rapidly dissolve thrombus through a proprietary dual-mode mechanism .
Integrated Clot Capture
The system combines synchronized aspiration with ultrasound-driven effects to collect clot fragments in real time and help minimize downstream embolization.
Continuous Safety Monitoring
Built-in temperature and pressure sensing provides real-time procedural feedback for controlled and reliable performance.
Patent-Pending Catheter Technology
Our catheter developed at ETH Zurich is designed to rapidly dissolve thrombus through a proprietary dual-mode mechanism .
Integrated Clot Capture
The system combines synchronized aspiration with ultrasound-driven effects to collect clot fragments in real time and help minimize downstream embolization.
Continuous Safety Monitoring
Built-in temperature and pressure sensing provides real-time procedural feedback for controlled and reliable performance.
Product Suite
Our product suite is designed for full PCI compatibility and user-friendly integration into interventional cardiology workflows. Its ultrasound console, ergonomic handpiece, and integrated catheter architecture enable intuitive operation, controlled activation, and real-time monitoring for safe, reproducible clinical use.
Product Suite
Our product suite is designed for full PCI compatibility and user-friendly integration into interventional cardiology workflows. Its ultrasound console, ergonomic handpiece, and integrated catheter architecture enable intuitive operation, controlled activation, and real-time monitoring for safe, reproducible clinical use.
Preclinical validation
Preclinical thrombolysis studies demonstrated vessel recanalization within seconds, as visualized by digital subtraction angiography, without thrombolytic drugs.
The CardioCare platform is built for PCI compatibility and user-friendly integration into interventional cardiology workflows.
Preclinical validation
Preclinical thrombolysis studies demonstrated vessel recanalization within seconds, as visualized by digital subtraction angiography, without thrombolytic drugs.
The CardioCare platform is built for PCI compatibility and user-friendly integration into interventional cardiology workflows.